Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Background: Since the warnings by the United States (US) and European regulatory authorities in 2004 and 2005 it had been discussed whether there is some link between selective serotonin reuptake inhibitors (SSRIs) and suicidality in the pediatric population. The aim of our study was to describe trends and patterns in spontaneous reporting data referring to suicidality in children, adolescents and young adults treated with SSRI after the warnings. Methods: Descriptive analyses of reports for 0–24 year olds referring to suicide/suicidal ideations, self-harms and overdoses with SSRIs reported as suspected submitted to the US (FAERS) and the European (EudraVigilance) adverse drug reaction databases until 2019 were performed. The causal relationship was assessed in accordance with the WHO criteria for the European reports. For Germany, prescription data for SSRIs were provided and reporting rates (number of reports/number of prescriptions) were calculated for the reports with possible causal relationship (so called “confirmed reports”). Results: Since 2004, the number of reports referring to suicide/suicidal ideations, self-harm and overdoses increased steadily in the US and EU. However, only a slight increase was seen for the confirmed EU reports. After 2008, the proportion of reports informing about suicidal ideations increased, while the proportion of fatal suicide attempts decreased. Reporting rates were higher for females and adolescents (12-18 years). Conclusions: Our results demonstrate the importance of further monitoring suicidality in 0–24 year olds treated with SSRI in order to recognize suicidality early avoiding fatal suicide attempts. The higher reporting rates for females and adolescents should be further investigated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 Annual number of reports from EudraVigilance and FAERS referring to intentional suicide/suicidal behaviour or overdose associated with SSRI. Legend to Fig. 2: EEA: European Economic Area; Confirmed EEA reports: reports from the European economic area with a possible causal relationship of suicidality related to SSRI treatment following causality assessment applying WHO criteria [20]. US: United States of America, FAERS: Food and Drug Administration (FDA) Adverse Event Reporting System](https://figures.cochat.ai/paper-figures/863e9334e93a44599274063e6ad42357/selective-serotonin-reuptake-inhibitors-and-suicidality-in-children-and-young-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The literature suggests that such interventions may lead to increased hyperactivity, irritability, impulsivity, and hostile behavior [45,76].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [76]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Other reported physical effects include gastrointestinal discomfort, such as abdominal pain or nausea, as well as sleep disturbances [45,76,78].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [76]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Merikangas, K. R., He, J.-P., Burstein, M., Swanson, S. A., Avenevoli, S., Cui, L., Benjet, C., Georgiades, K., & Swendsen, J. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.05.017 · Cited by 6,278 · cited 1×
“EU: In-depth analysis of ADR reports referring to suicidality The higher proportion of females in the confirmed EU reports may reflect more SSRI prescriptions [26, 27, 29] and diagnoses of juvenile depression and anxiety disorder [41] in females compared to males.”
BackgroundSuicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054 · cited 1×
“Background In 2004 [1] and 2005 [2], the United States of America and European regulatory authorities issued public health warnings based on data from randomized controlled trials (RCTs) suggesting that the risk of suicidal thinking and behavior (suicidal attempts, preparatory behavior and suicidal ideations) followin…”
BackgroundDepressed Adolescents Grown Up
Weissman, M. M. (1999) · JAMA · doi:10.1001/jama.281.18.1707 · Cited by 952
Cipriani, A., Zhou, X., Del Giovane, C., Hetrick, S. E., Qin, B., Whittington, C., Coghill, D., Zhang, Y., Hazell, P., Leucht, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30385-3 · Cited by 734 · cited 2×
“Some studies found no differences between the SSRIs [48] whereas others reported differences for patients with anxiety disorders with a higher risk of suicidality for paroxetine compared to sertraline [53].”
ResultGibbons, R. D., Brown, C. H., Hur, K., Marcus, S. M., Bhaumik, D. K., Erkens, J. A., Herings, R. M. C., & Mann, J. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07030454 · Cited by 605
Shaffer, D., & Pfeffer, C. R. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107001-00003 · Cited by 460
Relationship Between Antidepressant Medication Treatment and Suicide in Adolescents
Olfson, M. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.10.978 · Cited by 430 · cited 1×
“and confirmed cases per year As observed in the US [8, 52], an inverse relationship of increasing numbers of SSRI prescriptions and decreasing numbers of suicides was seen in the German data.”
ResultAnnual Research Review: A meta‐analytic review of worldwide suicide rates in adolescents
Glenn, C. R., Kleiman, E. M., Kellerman, J., Pollak, O., Cha, C. B., Esposito, E. C., Porter, A. C., Wyman, P. A., & Boatman, A. E. (2020) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13106 · Cited by 391 · cited 1×
“Risk factors that are assumed to increase the occurence of suicidality are, among others, an age of 10–24 years, depression and previous self-harm or suicide attempts [13, 14].”
BackgroundGlobal trends in teenage suicide: 2003–2014
McLoughlin, A. B., Gould, M. S., & Malone, K. M. (2015) · QJM · doi:10.1093/qjmed/hcv026 · Cited by 355 · cited 1×
“The decrease of the proportion of patients with a prior history of suicidal ideations or attempts from the pre- to the post-warning period might be related to a decrease of these patients being treated with SSRIs or a general decline of suicide attempts as fatal suicide attempts decreased in the analyzed period of tim…”
WICHSTRØM, L. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200005000-00014 · Cited by 324
Cited by
Wang, Y., Lin, Y., Lin, Q. H., Liang, H., Cai, W., & Jiang, D. (2023) · Scientific Reports · doi:10.1038/s41598-023-39482-y · Cited by 26
Chen, X., Dong, Y., Ye, M., Wang, X., Yan, J., Yao, Y., Zhou, Q., Qian, C., & Liu, Z. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06735-1 · Cited by 22
“One study describing suicidal tendencies in children and adolescents treated with SSRIs found that suicide-related behaviors and self-injury-related behaviors occurred primarily during the first three months of SSRI treatment [24].”
Treatment patterns of antidepressants in children and adolescents in Scandinavia
Rasmussen, L., Jensen, P. B., Reutfors, J., Furu, K., Skurtveit, S. O., Selmer, R. M., Damkier, P., Bliddal, M., & Wesselhoeft, R. T. (2024) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-024-02433-7 · Cited by 18
“Use of antidepressants in children and adolescents is debated due to the association between treatment with selective serotonin reuptake inhibitors (SSRIs) and increased risk of suicidal ideation and behavior [1–5].”
Zhao, Y., Zhang, Y., Yang, L., Zhang, K., & Li, S. (2024) · Annals of Pharmacotherapy · doi:10.1177/10600280241231116 · Cited by 15
Pediatric suicide: Review of a preventable tragedy
Greydanus, D. E., Nazeer, A., Qayyum, Z., Patel, D. R., Rausch, R., Hoang, L.-N., Miller, C., Chahin, S. S., Apple, R. W., Saha, G. K., et al. (2024) · Disease-a-Month · doi:10.1016/j.disamonth.2024.101725 · Cited by 13
Metadata
- Authors
- Dubrall, D., Fekete, S., Leitzen, S., Paschke, L. M., Romanos, M., Schmid, M., Gerlach, M., & Sachs, B.
- Affiliations
- Federal Institute for Drugs and Medical Devices (DE)
- Universitätsklinikum Würzburg (DE)
- University Hospital Bonn (DE)
- Corresponding author
- Fekete, Stefanie
- ORCID
- Venue
- BMC Pharmacology and Toxicology
- Published
- 2023-03-31
- Volume
- 24
- Issue
- 1
- Pages
- 22-22
- ISSN
- 2050-6511 (ISSN-L)
- PMC
- PMC10067298
- OpenAlex
- W4362523560
- Cited by
- 15
- References
- 43
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 5
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- BMC Pharmacology and Toxicology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- Funders
- Federal Institute for Drugs and Medical Devices
- Institute for Medical Biometry, Informatics, and Epidemiology
- University Hospital of Bonn
- German innovation fund of the Federal Joint Committee (01NVF16021)
- Universitätsklinikum Würzburg
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- selective serotonin reuptake inhibitors, suicidality, adverse drug reactions, suicide attempts, suicidal ideation, self-harm, drug overdose, pharmacovigilance, reporting rates, adolescents, sex differences
- MeSH terms
- Adolescent, Child, Female, Humans, Suicide, Suicide, Attempted, United States, Selective Serotonin Reuptake Inhibitors, Young Adult, Suicidal Ideation, Pharmacovigilance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases. https://app.cochat.ai/papers/10.1186/s40360-023-00664-z
- The paper
- Dubrall, D., Fekete, S., Leitzen, S., Paschke, L. M., Romanos, M., Schmid, M., Gerlach, M., & Sachs, B. (2023). Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases. BMC Pharmacology and Toxicology. https://doi.org/10.1186/s40360-023-00664-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.